Maryland HB 484: Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising

Status: Hearing 2/12 at 1:00 p.m. (as of 2026-01-23)

State: Maryland · Session: 2026 · Bill: HB 484

Sponsors: Addison, Charkoudian, Cullison, Ebersole, Feldmark, Guzzone, Hill, Moreno, Terrasa, Watson, Ziegler

View Maryland HB 484 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.